ARQT analyst estimates
Arcutis (ARQT) analyst ratings, the average price target and its range, and every firm's latest call.
ARQT analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 19, 2026 | Guggenheim | Arcutis Biotherapeutics price target raised to $44 from $38 at Guggenheim | $44.00 |
| Oct 15, 2026 | Cantor Fitzgerald | Arcutis Biotherapeutics initiated with an Overweight at Cantor Fitzgerald | $48.00 |
| Oct 8, 2026 | Jefferies | Jefferies Reiterates Buy Rating on Arcutis Biotherapeutics Inc. (ARQT) ahead of earnings | $39.00 |
| Aug 6, 2026 | Guggenheim | Arcutis Biotherapeutics Inc. (ARQT) PT Raised to $38 at Guggenheim | $38.00 |
| Aug 6, 2026 | Morgan Stanley | Arcutis Biotherapeutics price target raised to $38 from $34 at Morgan Stanley | $38.00 |
| Feb 26, 2026 | H.C. Wainwright | Arcutis Biotherapeutics Inc. (ARQT) PT Raised to $34 at H.C. Wainwright | $34.00 |
| Nov 28, 2025 | Mizuho Securities | Arcutis Biotherapeutics Inc. (ARQT) PT Raised to $37 at Mizuho | $37.00 |
| Oct 30, 2025 | Goldman Sachs | Arcutis Biotherapeutics price target raised to $29 from $19 at Goldman Sachs | $29.00 |
| Oct 29, 2025 | Mizuho Securities | Arcutis Biotherapeutics Inc. (ARQT) PT Raised to $32 at Mizuho | $32.00 |
| Oct 29, 2025 | H.C. Wainwright | Arcutis Biotherapeutics price target raised to $30 from $22 at H.C. Wainwright | $30.00 |
| Mar 11, 2025 | Jefferies | Arcutis Biotherapeutics price target raised to $19 from $16 at Jefferies | $19.00 |
| Dec 30, 2024 | H.C. Wainwright | Arcutis Biotherapeutics initiated with a Buy at H.C. Wainwright | $19.00 |
| May 15, 2024 | Mizuho Securities | Arcutis Biotherapeutics Inc. (ARQT) PT Raised to $18 at Mizuho | $18.00 |
| May 15, 2024 | Needham | Arcutis Biotherapeutics Inc. (ARQT) PT Raised to $18 at Needham | $18.00 |
| Jan 2, 2024 | Mizuho Securities | Arcutis Biotherapeutics Inc. (ARQT) PT Raised to $8 at Mizuho Securities, Upgraded to Buy | $8.00 |
- 7 firms rate ARQT: 7 buy, 0 hold, 0 sell.
- The average price target is $42.25 from 4 analysts, from $38.00 to $48.00.
Updated 2026-11-03 00:02 UTC